ESH/LinkedIn
Mar 3, 2026, 15:16
Transplant vs CAR T Cells in Multiple Myeloma Debate at ESHMM 2026 – ESH
European School of Haematology (ESH) shared a post on LinkedIn:
“Programme Highlight of ESHMM 2026!
Debate 3 – Transplant vs CAR T cells.
Moderated by Martin Kaiser with Mohamad Mohty and Robert Orlowski (with audience voting)
Less than a month to go before the conference begins!
Secure your spot today — Register now and Join us on March 26-28, 2026 in Stockholm, Sweden.
8th Translational Research Conference on Multiple Myeloma.
Conference Chairs: Hartmut Goldschmidt, Martin Kaiser, Suzanne Lentzsch”
Stay updated with Hemostasis Today.
-
Sep 6, 2026, 18:17Aryabhatta Sadhu: Irradiation of Blood Components – From Clinical Indication to Laboratory Release
-
Sep 6, 2026, 18:15Ashenafi Tazebew Amare: A Year of Progress, Transformation and Renewed Commitment
-
Sep 6, 2026, 18:13Emilio Osorio: Can Anticoagulation Be Safely Discontinued After Surgical Left Atrial Appendage Occlusion?
-
Sep 6, 2026, 18:11Razan Alolyani: Our Research on Anticoagulation After Acute Ischemic Stroke Receives 2nd Place
-
Sep 6, 2026, 18:10Chayakrit Krittanawong: Have You Heard of Blood Clots in the Legs?
-
Sep 6, 2026, 18:08Trilok Chand: Microplastics Found in Human Testes and Blood Clots
-
Sep 6, 2026, 18:07Sarah Moharem Elgamal: Cardiovascular Imaging Beyond Anatomy Toward Earlier Risk Prediction
-
Sep 6, 2026, 16:41Christina P.: APS – How it Happens in Your Blood, the Warning Signs, and What to Do about It
-
Sep 6, 2026, 16:33Jose Angel Nicolas Avila: How Tissue Mitochondrial Activity Dictates Macrophage Pool Size